Decreased levels of uric acid after oral glucose challenge is associated with triacylglycerol levels and degree of insulin resistance

British Journal of Nutrition

Volumn 99, Issue 1, 2008, Pages 44-48

  Tinahones, F J ^a,f   Cardona, F ^a   Rojo Martinez G ^b   Almaraz, M C ^c   Cardona, I ^b   Vazquez Mellado J ^d   Garrido Sanchez L ^b   Collantes, E ^e   Soriguer, F ^c  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^b Hospital University Carlos Haya de Málaga   (Spain)

^c HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^d HOSPITAL GENERAL DE MÉXICO   (Mexico)

^e HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^f INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Insulin resistance; OGTT; Triacylglycerol; Uric acid

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; PLASMA PROTEIN; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; ORAL GLUCOSE TOLERANCE TEST; PREDICTION; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; VARIANCE; WAIST HIP RATIO;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; CHOLESTEROL; CHOLESTEROL, HDL; FEMALE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; OXIDATIVE STRESS; REGRESSION ANALYSIS; TRIGLYCERIDES; URIC ACID;

EID: 37349013201     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114507787470     Document Type: Article

References (36)

1. Zavaroni I, Mazza S, Fantuzzi M, Dall'Aglio E, Bonora E, Delsignore R, Passeri M & Reaven GM (1993) Changes in insulin and lipid metabolism in males with asymptomatic hyperuricaemia. J Intern Med 234, 25-30.
2. Rathman W, Funkhouser E, Dyer AR & Roseman JM (1998) Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: The Cardia Study. Ann Epidemiol 8, 250-261.
3. Culleton BF, Larson MG, Kannel WB & Levy D (1999) Serum uric acid and risk for cardiovascular disease and death: The Framingham Heart Study. Ann Intern Med 131, 7-13.
4. Cardona F, Tinahones FJ, Collantes E, Escudero A, Garcia-Fuentes E & Soriguer FJ (2005) Contribution of polymorphisms in the apolipoprotein AI-CIII-AIV cluster to hyperlipidaemia in patients with gout. Ann Rheum Dis 64, 85-88.
5. Cardona F, Tinahones FJ, Collantes E, Escudero A, Garcia-Fuentes E & Soriguer FJ (2003) The elevated prevalence of apolipoprotein E2 in patients with gout is associated with reduced renal excretion of urates. Rheumatology (Oxford) 42, 468-472.
6. Cardona F, Tinahones FJ, Collantes E, Garcia-Fuentes E, Escudero A & Soriguer F (2005) Response to a urate-lowering diet according to polymorphisms in the apolipoprotein AI-CIII-AIV cluster. J Rheumatol 32, 903-905.
7. Tinahones JF, Pérez-Lindon G, C-Soriguer FJ, Pareja A, Sánchez-Guijo P & Collantes E (1997) Dietary alterations in plasma very low density lipoprotein levels modify renal excretion of urates in hyperuricemic-hypertriglyceridemic patients. J Clin Endocrinol Metab 82, 1188-1191.
8. Facchini F, Chen YD, Hollenbeck CB & Reaven GM (1991) Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 266, 3008-3011.
9. Quinones Galvan A, Natali A, Baldi S, Frascerra S, Sanna G, Ciociaro D & Ferrannini E (1995) Effect of insulin on uric acid excretion in humans. Am J Physiol 268, E1-E5.
10. Cardona F & Tinahones FJ (2006) The missing link in the metabolic syndrome: Postprandial hyperlipidemia and oxidative stress. Endocrinología 53, 345-352.
11. Berry CE & Hare JM (2004) Xanthine oxidoreductase and cardiovascular disease: Molecular mechanisms and pathophysiological implications. J Physiol 16, 589-606.
12. Farquharson CA, Butler R, Hill A, Belch JJ & Struthers AD (2002) Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation 106, 221-226.
13. Waring WS, Webb DJ & Maxwell SR (2001) Systemic uric acid administration increases serum antioxidant capacity in healthy volunteers. J Cardiovasc Pharmacol 38, 365-371.
14. Waring WS, Convery A, Mishra V, Shenkin A, Webb DJ & Maxwell SR (2003) Uric acid reduces exercise-induced oxidative stress in healthy adults. Clin Sci (Lond) 105, 425-430.
15. Ceriello A (1997) Acute hyperglycaemia and oxidative stress generation. Diabet Med 14, S45-S49.
16. Ceriello A, Bortolotti N, Motz E, Crescentini A, Lizzio S, Russo A, Tonutti L & Taboga C (1998) Meal-generated oxidative stress in type 2 diabetic patients. Diabetes Care 21, 1529-1533.
17. Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414, 813-820.
18. Ceriello A, Bortolotti N, Crescentini A, Motz E, Lizzio S, Russo A, Ezsol Z, Tonutti L & Taboga C (1998) Antioxidant defenses are reduced during oral glucose tolerance test in normal and non-insulin dependent diabetic subjects. Eur J Clin Invest 28, 329-333.
19. Tessier D, Khalil A & Fulop T (1999) Effects of an oral glucose challenge on free radicals/antioxidants balance in an older population with type II diabetes. J Gerontol 54, 541-545.
20. Konukoglu D, Hatemi H, Ozer EM, Gonen S & Akcay T (1997) The erythrocyte glutathione levels during oral glucose tolerance test. J Endocrinol Invest 20, 471-475.
21. Zou MH, Shi C & Cohen RA (2002) Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J Clin Invest 109, 817-826.
22. Rojo-Martinez G, Esteva I, Ruiz de Adana MS, Garcia-Almeida JM, Tinahones F, Cardona F, Morcillo S, Garcia-Escobar E, Garcia-Fuentes E & Soriguer F (2006) Dietary fatty acids and insulin secretion: A population-based study. Eur J Clin Nutr 60, 1195-1200.
23. Andalusian Statistics Institute (1996) Municipal information system of Andalusia. Seville Andalusian Parliament.
24. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC (1985) Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419.
25. Ceriello A, Bortolotti N, Motz E, Pieri C, Marra M, Tonutti L, Lizzio S, Feletto F, Catone B & Taboga C (1999) Meal-induced oxidative stress and low-density lipoprotein oxidation in diabetes: The possible role of hyperglycemia. Metabolism 48, 1503-1508.
26. Ceriello A (2003) The possible role of postprandial hyperglycaemia in the pathogenesis of diabetic complications. Diabetologia 46, M9-M16.
27. Benzie IF, Chung W & Tomlinson B (1999) Simultaneous measurement of allantoin and urate in plasma: Analytical evaluation and potential clinical application in oxidant:aNtioxidant balance studies. Clin Chem 45, 901-904.
28. Ozguner F, Armagan A, Koyu A, Caliskan S & Koylu H (2005) A novel antioxidant agent caffeic acid phenethyl ester prevents shock wave-induced renal tubular oxidative stress. Urol Res 33, 239-243.
29. Elmas O, Aslan M, Caglar S, Derin N, Agar A, Aliciguzel Y & Yargicoglu P (2005) The prooxidant effect of sodium metabisulfite in rat liver and kidney. Regul Toxicol Pharmacol 42, 77-82.
30. McNally JS, Saxena A, Cai H, Dikalov S & Harrison DG (2005) Regulation of xanthine oxidoreductase protein expression by hydrogen peroxide and calcium. Arterioscler Thromb Vasc Biol 25, 1623-1628.
31. Mueller CF, Laude K, McNally JS & Harrison DG (2005) ATVB in focus: redox mechanisms in blood vessels. Arterioscler Thromb Vasc Biol 25, 274-278.
32. Collantes E, Tinahones FJ, Cisnal A, Anon J & Sanchez-Guijo P (1994) Variability of lipid phenotypes in hyperuricaemic-hyperlipidemic patients. Clin Rheumatol 13, 244-247.
33. Fox IH, John D, DeBruyne S, Dwosh I & Marliss EB (1985) Hyperuricemia and hypertriglyceridemia: Metabolic basis for the association. Metabolism 34, 741-746.
34. Collantes Estevez E, Pineda Priego M, Anon Barbudo J & Sanchez Guijo P (1990) Hyperuricemia-Hyperlipemia association in the absence of obesity and alcohol abuse. Clin Rheumatol 9, 28-31.
35. Ceriello A, Assaloni R, Da Ros R, Maier A, Piconi L, Quagliaro L, Esposito K & Giugliano D (2005) Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients. Circulation 111, 2518-2524.
36. Ceriello A & Motz E (2004) Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 24, 816-823.